| Sentara Health Plans Avalon | M2114: Pancreatic Cancer Risk Testing Using Pancreatic Cyst Fluid | 2026-05-01 |
| Sentara Health Plans Avalon | M2141: Testing of Homocysteine Metabolism-Related Conditions | 2026-05-01 |
| Sentara Health Plans Avalon | M2145: General Genetic Testing Germline Disorders | 2026-05-01 |
| Sentara Health Plans Avalon | M2146: General Genetic Testing Somatic Disorders | 2026-05-01 |
| Sentara Health Plans Avalon | M2168: Proteogenomic Testing of Individuals with Cancer | 2026-05-01 |
| Sentara Health Plans Avalon | M2175: Minimal Residual Disease (MRD) | 2026-05-01 |
| Sentara Health Plans Avalon | M2176: Testing for Developmental Delay | 2026-05-01 |
| Sentara Health Plans Avalon | M2178: Microsatellite Instability and Tumor Mutational Burden Testing | 2026-05-01 |
| Sentara Health Plans Avalon | P2018: Immunohistochemistry | 2026-05-01 |
| Sentara Health Plans Avalon | R2162: Laboratory Procedures Reimbursement Policy | 2026-05-01 |